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Introduction
The expression of the members of the TNF big family, namely the receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), which is accompanied by the expression and signaling through the receptor activator of NF-kB (RANK) plays an important role in bone remodeling. RANKL/RANK signaling regulates the formation of osteoclast, activation and survival of normal bone modeling and remodeling, and is involved in various pathological conditions characterized by the increase of bone turnover, such as osteoporosis. OPG protects bones from excessive resorption through binding to RANKL and prevents it to bind to RANK. RANKL and OPG concentrations in the bone will determine bone mass and strength [1] . It is very important to maintain the balance of bone formation and resorption, where the imbalance will cause the decrease in bone mineral density that may trigger the increase in osteoporosis risks [2] .
In the last few years, many researchers state that phytochemical materials or plant derivatives components are able to help maintain bone health. Labisia pumila or in Malay language known as Kacip Fatimah or Rumput Fatimah contains high content of phenolic acids and flavonoids. Phenolic acids and flavonoids are believed to play an important role in the plant pharmacological activity. L. pumila is widely used as herbal medicines in Southeast Asia for various kinds of diseases [3] . L. pumila contains some flavonoids such as apigenin, kaempferol, rutin and myricetin. Pumila Labisia contains several phenol such as gallic acid, pyrogallol and caffeic acid [3, 4] . Phenolic acids and flavonoids play an essential role in the pharmacological activity in many plants [5] .
L. pumila is widely used not only to relieve pain during menstruation, enhance sexual function, but it is also used as an alternative hormone replacement therapy for postmenopausal women [6, 7] . Postmenopausal women are susceptible to osteoporosis due to low estrogen. Estrogen plays a role in the form of estrogen receptor-a (ERa) and receptor-b (ERb) having high affinity against the osteoblasts and osteoclasts [8] . The activation of the estrogen receptor complex is very vital to maintain bone remodeling process [9] . Estrogen can induce and inhibit osteoclast apoptosis, which indirectly will reduce bone resorption and enhance bone formation activity [10] . Thus, the wide range of active compounds of L. pumila extract is supposedly used as anti-osteoporosis agent. Data of this research will be analyzed insilico basis to determine the interaction of the active ingredients in L. pumila (kaempferol, rutin, apigenin, caffeic acid, pyrogallol and gallic acid) against RANKeRANKLeOPG system.
Material and methods

Ligand preparation
The 3D-structures of kaempferol, rutin, apigenin, caffeic acid, pyrogallol and gallic acid compounds were obtained from NCBI PubChem (kaempferol ID: CID5280805, rutin ID: CID5280805, apigenin ID: CID5280443, pyrogallol ID: CID1057 and gallic acid ID: CID370). After that, the 3D structures are in the form of file.sdf converted into PDB format using Open Babel 2.3.1 software.
Protein receptor of RANKeRANKLeOPG
The 3D-structure model of RANKeRANKL PDB ID: 3ME2 and RANKL-OPG PDB ID 4E4D was obtained from http://www.rcsb.org/pdb. The protein validation was analyzed by Ramachandran plot [11e13].
Ligandeprotein docking and visualization
Software Hex8.0 is a rigid docking used as a device to calculate the interaction probability of kaempferol, rutin, apigenin, caffeic acid, pyrogallol and gallic acid with RANKeRANKL and RANKLeOPG. The result will illustrate the interaction of their active properties and their visualization and Ramachandran plot is analyzed using Discovery Studio Client 3.5 software [14, 15] .
Results
The results of docking between RANKeRANKL and RANKeOPG complex bonds with the active ingredients of L. pumila (kaempferol, rutin, apigenin, caffeic acid, pyrogallol and gallic acid) show that all compounds from L. pumila interact with RANKeRANKL and RANKeOPG complex. RANKeRANKL complex has the easiest interaction with rutin (À313.0 kJ/mol) and has the most difficult interactions with pyrogallol (À136.3 kJ/mol) ( Table 1) .
Meanwhile, the complex interaction of RANKLeOPG with the active ingredients, in which the RANKLeOPG complex has the highest interaction with rutin (À322.0 kJ/mol) and has the lowest interaction with pyrogallol (À136.3 kJ/mol) ( Table 2 ).
Discussion
Bone remodeling involves the balance between bone formation and resorption. The disruption of the balance between the two processes will trigger bone pathology. There are several factors or cytokines known to play important roles in bone remodeling process. The bone remodeling is regulated by receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG), produced by osteoblasts [16] RANK binds to RANKL receptors located in osteoclast precursors to trigger differentiation into mature osteoclasts and then provokes bone resorption [17] . The study indicates that the administration of RANKL serum to mice may trigger the growth and activation of osteoclasts that leads to osteoporosis [18] . The docking results show the interaction between the active ingredients of L. pumila with RANKeRANKL complex. The RANKeRANKL complex has the highest interaction with rutin (À313.0 kJ/mol) and has the lowest interaction with pyrogallol (À136.3 kJ/mol). It indicates that the rutin is the potential active ingredient that is able to interact with RANKeRANKL complex the most. Previous research has shown that rutin can inhibit osteoclast formation induced by RANKL [19] .
Meanwhile, as for the interaction in the system of RANKLeOPG, OPG acts as the anti-resorption receptor that binds RANKL and prevents it from binding to RANK. As a result, OPG inhibits osteoclast differentiation and bone resorption activity. In this research, there is the interaction between RANKLeOPG complex and the active ingredient, in which the RANKLeOPG complex has the highest interaction with rutin (À322.0 kJ/mol) and has the lowest interaction with pyrogallol (À136.3 kJ/mol). It also indicates that rutin is the most potential active ingredient that is easiest to interact with RANKLeOPG complex. Our finding extends previous study that rutin can inhibit osteoclast formation induced by RANKL [19] . The rutin interaction with RANKLeRANK and RANKLeOPG systems confirms its role as an antiosteoporosis agent, consistent with previous studies [20] . Isoflavonoid components include pyrogallol, caffeic acid, and gallic acid. Meanwhile, kaempferol, rutin and apigenin, are classified as a flavonoid component. Thus, in this study, it has been proven that the interaction of RANKeRANKL and RANKLeOPG is easier on the flavonoid compound than isoflavonoid compound of L. pumila. This leads to the ease of interaction of flavonoids versus isoflavonoid will increase the effectiveness in bone and reduce side effects. These findings expanded earlier findings that isoflavonoid may provide side effects in during long-term administration of estrogen sensitive organs [21] .
In conclusion, flavonoid compounds (rutin, apigenin, kaempferol) more easily interact with RANKeRANKL and RANKLeOPG systems than isofavonoid groups (caffeic acid, pyrogallol, gallic acid). This opens the opportunity for the utilization of flavonoid from L. pumila as antiosteoporosis. 
